FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
TNKase is delivered as a single five-second intravenous (IV) bolus, [...]
TNKase is delivered as a single five-second intravenous (IV) bolus, [...]
The decision by Co-Diagnostics to withdraw the submission was based [...]
Manfred Rüdiger, Chief Executive Officer at Ariceum Therapeutics, said: “Receiving [...]
In a clinical trial involving 340 patients across seven institutions, [...]
RapidAI continues to pioneer AI advances by revolutionizing 3D imaging [...]
“This first release of our TAVIPILOT software marks an important [...]
“Receiving Fast Track designation from the FDA reinforces the potential [...]
Christopher M. Owens, President and Chief Executive Officer of R3 [...]
The Truliant Porous Tibial Tray leverages additive manufacturing technology to [...]
With this FDA clearance, the MagDI System is poised to [...]